MIRA INFORM REPORT

 

 

 

Report Date :

18.12.2008

 

IDENTIFICATION DETAILS

 

Name :

GENCOR  PACIFIC  LTD.

 

 

Registered Office :

Flat E, 21/F., Elegance Court, Hillgrove Village, Discovery Bay, Lantau Island

 

 

Country :

Hong Kong 

 

 

Date of Incorporation :

15.01.1999.

 

 

Com. Reg. No.:

22227856

 

 

Legal Form :

Private Limited Company.

 

 

Line of Business :

Importer, Exporter and Wholesaler of Raw materials for vitamin, vitamin, etc.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

 

Name

 

GENCOR  PACIFIC  LTD.

 

 

ADDRESS

 

Flat E, 21/F., Elegance Court, Hillgrove Village, Discovery Bay, Lantau Island, Hong Kong.

PHONE:                  2987 6894,  2987 6814

FAX:                       2987 6869

E-MAIL:                  gencor@netvigator.com

venkat@gencorpacific.com

 

 

MANAGEMENT

 

Managing Director:  Mr. Ramasamy Varada Rajan Venkatesh

 

 

SUMMARY

 

Incorporated on:                15th January, 1999.

 

Organization:                     Private Limited Company.

 

Capital:                             Nominal:     HK$1,500,000.00

                                        Issued:        HK$1,500,000.00

 

Business Category:             Importer, Exporter and Wholesaler.

 

Employees:                         5.

 

Main Dealing Banker:          Indo Hong Kong International Finance Ltd., Hong Kong.

 

Banking Relation:                 Satisfactory.

 

 

ADDRESS

 

Registered Office:-

c/o Multi-Chain Ltd.

Room 301, 3/F., Kam On Building, 176A Queen’s Road Central, Hong Kong.   [Tel: 2543 0565;  Fax: 2854 3813]


Head Office:-

Flat E, 21/F., Elegance Court, Hillgrove Village, Discovery Bay, Lantau Island, Hong Kong.

 

Affiliated Companies:

Genapk, South Africa.

GPI Pty. Ltd., Botswana.

Rubber General Industries, India.

 

 

BUSINESS REGISTRATION NUMBER

 

22227856

 

 

COMPANY FILE NUMBER

 

664999

 

 

MANAGEMENT

 

Managing Director:  Mr. Ramasamy Varada Rajan Venkatesh

 

 

CAPITAL

 

Nominal Share Capital: HK$1,500,000.00 (Divided into 150,000 shares of HK$10.00 each)

 

Issued Share Capital: HK$1,500,000.00

 

 

SHAREHOLDERS

(As per registry dated 08-04-2008)

 

Name

 

No. of shares

Mr. Jith VEERAVALLI

 

2

Mrs. Chitra VEERAVALLI

 

118,498

Mrs. Aruna VENKATESH

 

30,000

Mr. Srinath VENKATARAMANAN

 

1,500

 

 

–––––––

 

Total:

150,000

======

 


DIRECTORS  

(As per registry dated 08-04-2008)

Name

(Nationality)

 

Address

Srinath VENKATARAMANAN

24-C, P.T. Rajan Road, K.K. Nagar, Chennai 600078, Tamil Nadu, India.

 

Jith VEERAVALLI

   (American)

Room 301, 3/F., Kam On Building, 176A Queen’s Road Central, Hong Kong.

 

Ramasamy Varada Rajan VENKATESH

   (Indian)

Unit 1-B, 20 Coastline Villa, Discovery Bay, Lantau Island, Hong Kong.

 

 

SECRETARY 

(As per registry dated 15-01-2008)

 

Name

Address

Co. No.

Multi-Chain Ltd.

Room 301, 3/F., Kam On Building, 176A Queen’s Road Central, Hong Kong.

209214

 

 

HISTORY

 

The subject was incorporated on 15th January, 1999 as a private limited liability company under the Hong Kong Companies Ordinance.

Apart from these, neither material change nor amendment has been ever traced and noted.

 

OPERATIONS

 

Activities:                                 Importer, Exporter and Wholesaler.

 

Lines:                                       Raw materials for vitamin, vitamin, etc.

 

Employees:                               2.

 

Commodities Imported:              Mainly imported from India.

 

Markets:                                   Hong Kong, China, South Africa, etc.

 

Terms/Sales:                             As per contracted.

 

Terms/Buying:                           L/C, D/P, T/T, etc.

 


FINANCIAL INFORMATION

 

Nominal Share Capital: HK$1,500,000.00 (Divided into 150,000 shares of HK$10.00 each)

 

Issued Share Capital: HK$1,500,000.00

 

Alternation of Capital:-

15-01-1999

paid up

HK$        500,000.00

05-07-2000

paid up

HK$        500,000.00

08-04-2008

paid up

HK$        500,000.00

 

 

–––––––––––––––

Total:

paid up

HK$     1,500,000.00

==============

 

Increase of Nominal Capital:-

From

HK$500,000.00

to

HK$1,500,000.00

on

05-07-2000

 

 

Mortgage or Charge:  (See attachment)

 

Profit & Loss:                                        Operation is rather profitable.

 

Condition:                                              Business is active.

 

Facilities:                                              Making active use of general banking facilities.

 

Payment:                                              Met as required.

 

Commercial Morality:                             Fair.

 

Banker:                                                 Indo Hong Kong International Finance Ltd., Hong Kong.

 

Standing:                                              Small.

 

 

GENERAL

 

Formerly Gencor Pacific Ltd. issued 100,000 ordinary shares of HK$10.00 each and jointly owned by Mr. Vatsha Rajan Veeravalli, holding 1 share; Mr. Jith Veeravalli, holding 1 share; Mrs. Rajan Veeravalli, 49,999 shares; and Mrs. Chitra Veeravalli also 49,999 shares.

Subsequently, the subject’s issued share capital was increased to HK$1,500,000.00 and the shareholders have been reshuffled.  Now, the subject is chiefly owned by Mrs. Chitra Veeravalli, holding 79.0% interest; Mrs. Aruna Venkatesh, holding 20%; and Mr. Srinath Venkataramanan, 1%.

The subject is dealing in raw materials for manufacturing vitamin, classical herbs, medicines.  It has got affiliated factories in India and South Africa.  Products are marketed in Hong Kong, China, the Middle East, Africa, North America, Central and South America, etc.  The subject has claimed that China is its principal market.  Business has been active and steady.

The subject carries the following products:-

Indian Manufactured Botanical Ingredients

·         Adhatoda Vasica Extract Standardised for 1% Vasicine

·         Agave Sisalana Extract Standardised for Tigogenin and Hecogenin

·         Aloe Perryi Soft Extract and Transparent Gel

·         Bacopa Monnieri (Bacosides 20-50%)

·         Bamboo Shoot Extract with 75% Natural Silicon Content

·         Bamboo Shoot Extract with 50% Natural Silicon Content Fortified with Bioflavonoids

·         Calendula Officinalis Extract

·         Capsaicin 95% USP

·         Curcuma Longa (Curcuminoids 95%)

·         Eclipta Alba Extract with 10% Tannins

·         Evolvudus Alsinoides Extract

·         Fenugreek Extract Containing upto 40% 4-Hydroxy Isoleucine by HPLC

·         Fenugreek Extract Standardised for 13.5% and 20% 4‑Hydroxyisoleucine, Stabilised, De-Odorised and Taste Masked

·         Fenugreek Extract Containing upto 50% Fenuside by HPLC

·         Garcinia Cambogia (50%, 60% HCA, 75% Calcium, Sodium and Potassium Salts)

·         Garlic Extract Standardised for Allicin

·         Hibiscus Sabdariffa Extract Standardised for Flavonoids and Polyphenols

·         Hyoscyamus Muticus Extract 0.3% Hyoscyamine

·         IPECAC Root Powder

·         L-Arginine Natural Extracted from Raisins

·         L-Citrulline Natural Extracted from Water Melons

·         L-Selenomethionine 99%

·         Mangosteen Extract Standardised for 50% Xanthones

·         Marigold Extract Standardised for Xanthophylls

·         Neem Extract upto 20% Bitters

·         Nigella Sativa Extract Standardised for 0.2% Thymoquinone by HPLC

·         Ocimum Sanctum (Holy Basil) Extract

·         Papain Crude and Pure, Standardised for Usp Units and Tyrosine Units

·         Passiflora Incarnata Extract with 3% Vitexins

·         Red Clover Extract with 8% Isoflavones

·         Red Clover Extract with 4% Estrone and 5% Estradiol

·         Red Clover Extract Standardised for Coumestrol

·         Salacia Reticulate Extract with 20% Saponins

·         Safed Musli Extract Standardised for upto 40% Saponins

·         Selenomethionine: Dcp Triturate with 0.5% Selenium

·         Tamarindus Indica Extract

·         Tanacetum Parthenium Extract

·         Tinospora Cordifolia Extract with 2% Alkaloids and 5% Bitters

·         UVA Ursi Extract

·         Valerian Extract with 0.8% Valerenic Acids

·         Vitex Agnus Castus with Standardisation upto 10% Vitexin and 0.5% Agnusides

·         Wild Yam Extract with 20% Steroidal Saponins and upto 16% Diosgenin

·         Witch Hazel Soft Extract

·         Zinc Methionine


Partner Products Manufactured in South East Asia

From Malaysia

·         Eurycoma Longifolia Extract

 

From Thailand

·         Butea Superaba Extract

·         Clinacanthus Nutans Extract

·         Ipomoea Extract

·         Mangosteen Extract

·         Pueraria Mirifica Extract

·         Perilla Extract

·         Tinospora Crispa Extract

 

The subject’s registered office is located at an accounting firm known as Multi-Chain Ltd. [Multi-Chain] which is jointly owned by an Indian couple, Mr. Charanjit S. Grewal and Mrs. Kuldip Kaur Grewal.  Besides an accounting firm, Multi-Chain is also a secretarial firm offering all kinds of commercial services.  The business names of Multi-Chain are Grewal Commercial Services and Indian Movie Centre.

Since the history of the subject is about ten years in Hong Kong, consider it good for normal business engagements.

 

REMARKS:

 

Court Cases:           None per our.

 

Property information of the company:-

 

Property Location:          Flat B on 1/F., 20 Discovery Bay Road, Coastline Villa of Peninsula Village, Discovery Bay City, Discovery Bay, Lantau Island, Hong Kong.

 

Owner:  Gencor Pacific Ltd.

 

Date of Purchase:  n.a.

 

Purchased Price:  n.a.

 

Incumbrances:-

Date of Mortgage

Amount Consideration

Mortgagee

Nature

13-07-2007

-

Canara Bank, Hong Kong Branch.

Mortgage to secure general banking facilities

 


MORTGAGE OR CHARGE

 

Date

Particulars

Amount

25-01-2000

Instrument:      Undertaking Relating to Deposits

Property:

Deposit Receipt No.:         63/990101
Date:                               25-11-1999
Amount:                           US$25,000
Rate of Interest:                5.59%
Due Date:                         25-02-2000

Mortgagee:      Indo Hong Kong International Finance Ltd., Hong Kong.

Banking facilities

10-01-2003

Instrument:      Undertaking Relating to Deposits

Property:

Fixed Deposit          Amount       Rate of         Maturity
Receipt No.             Date              (US$)        Interest         Date   

42/220165         23-12-2002       70,417.74       0.79%      24-03-2003
42/220124         23-09-2002       85,535.36       1.18%      24-03-2003

Mortgagee:      Indo Hong Kong International Finance Ltd., Hong Kong.

General credit facilities

14-06-2007

Instrument:      Undertaking Relating to Deposits

Property:

                                                Amount        Rate of      Maturity
Receipt No.             Date              (US$)        Interest         Date   

FD12.1.2007      26-03-2007         335,437.30   4.75%      26-06-2007
FD20.1.2007      30-03-2007         180,000.00   4.75%      03-07-2007
FD30.1.2007      12-04-2007         100,000.00   4.75%      12-07-2007
FD40.1.2007      10-04-2007          51,241.28   4.74%      10-07-2007
KD14.1.2007     23-05-2007          51,839.97   4.75%      23-11-2007

Mortgagee:      Canara Bank, Hong Kong Branch.

General credit facility

13-07-2007

Instrument:      Mortgage

Property:

11,834/250,000th parts or shares of and in The Remaining Portion of Lot No. 385 in Demarcation District No. 352 (Flat B on 1/F. of 20 Discovery Bay Road, Coastline Villa of Peninsula Village, Discovery Bay City, Discovery Bay, Lantau Island, Hong Kong.)

Mortgagee:      Canara Bank, Hong Kong Branch.

General banking facilities


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.47.33

UK Pound

1

Rs.73.92

Euro

1

Rs.66.69

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions